Xencor Inc (NASDAQ:XNCR)

36.25
Delayed Data
As of Oct 21
 +1.17 / +3.34%
Today’s Change
27.75
Today|||52-Week Range
46.33
+0.25%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.0B

Company Description

Xencor, Inc. engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.

Contact Information

Xencor, Inc.
111 West Lemon Avenue
Monrovia California 91016
P:(626) 305-5900
Investor Relations:

Employees

Shareholders

Mutual fund holders70.75%
Individual stakeholders31.68%
Other institutional27.52%

Top Executives

There are no executives to display.